Novel Antibiotics for Multidrug-Resistant Gram-Positive Microorganisms

Increasing multidrug-resistance to Gram-positive pathogens, particularly to staphylococci, enterococci and streptococci, is a major problem, resulting in significant morbidity, mortality and healthcare costs. In recent years, only a small number of novel antibiotics effective against Gram-positive b...

Descripción completa

Detalles Bibliográficos
Autores principales: Koulenti, Despoina, Xu, Elena, Yin Sum Mok, Isaac, Song, Andrew, Karageorgopoulos, Drosos E., Armaganidis, Apostolos, Lipman, Jeffrey, Tsiodras, Sotirios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723731/
https://www.ncbi.nlm.nih.gov/pubmed/31426596
http://dx.doi.org/10.3390/microorganisms7080270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723731/
https://www.ncbi.nlm.nih.gov/pubmed/31426596
http://dx.doi.org/10.3390/microorganisms7080270

Ejemplares similares